What is Interparfums' operating income?

Interparfums' total operating income in 2024 was $274.80 million, based on the following breakdown: Total Gross Profit: $927.34 million Total Operating Expenses: $652.55 million

Interparfums (IPAR) Financials

$133.22 -2.34 (-1.72%)

Closing price 03:59 PM Eastern

Extended Trading

$133.12 -0.11 (-0.08%)

As of 04:04 PM Eastern

Compare

Annual Income Statements for Interparfums

This table shows Interparfums' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	29	30	33	42	54	60	38	87	121	153	164
Consolidated Net Income / (Loss)	37	39	43	55	70	76	50	110	151	188	203
Net Income / (Loss) Continuing Operations	37	39	43	55	70	76	50	110	151	188	203
Total Pre-Tax Income	57	60	67	78	96	105	69	151	194	250	268
Total Operating Income	53	61	67	79	95	105	70	148	194	251	275
Total Gross Profit	287	289	326	376	428	446	331	557	694	839	927
Total Revenue	499	469	521	591	676	714	539	880	1,087	1,318	1,452
Operating Revenue	499	469	521	591	676	714	539	880	1,087	1,318	1,452
Total Cost of Revenue	212	179	195	215	248	268	208	323	392	479	525
Operating Cost of Revenue	212	179	195	215	248	268	208	323	392	479	525
Total Operating Expenses	234	228	260	298	333	341	261	409	500	588	653
Selling, General & Admin Expense	234	228	259	296	333	341	261	406	492	588	649
Impairment Charge	0.00	0.00	5.66	2.12	-	0.00	0.00	2.39	7.75	0.00	4.01
Total Other Income / (Expense), net	3.31	-0.71	0.40	-0.56	1.13	0.42	-0.73	2.92	-0.08	-1.79	-6.41
Interest Expense	1.48	2.83	2.34	1.99	2.58	2.15	1.97	2.83	3.60	11	7.83
Interest & Investment Income	3.89	3.00	3.33	2.98	3.96	3.69	2.87	3.40	5.49	11	2.22
Other Income / (Expense), net	0.90	-0.88	-0.60	-1.55	-0.25	-1.13	-1.63	2.34	-1.97	-1.27	-0.80
Income Tax Expense	19	22	24	23	26	29	19	41	43	62	65
Net Income / (Loss) Attributable to Noncontrolling Interest	7.91	8.53	9.92	14	16	16	12	23	30	35	39
Basic Earnings per Share	$0.95	$0.98	$1.07	$1.33	$1.72	$1.92	$1.21	$2.76	$3.80	$4.77	$5.13
Weighted Average Basic Shares Outstanding	30.93M	31.00M	31.07M	31.17M	31.31M	31.45M	31.54M	31.68M	31.86M	31.99M	32.04M
Diluted Earnings per Share	$0.95	$0.98	$1.07	$1.33	$1.71	$1.90	$1.21	$2.75	$3.78	$4.75	$5.12
Weighted Average Diluted Shares Outstanding	31.06M	31.10M	31.18M	31.31M	31.52M	31.69M	31.65M	31.84M	31.99M	32.14M	32.12M
Weighted Average Basic & Diluted Shares Outstanding	31M	31.10M	31.20M	31.30M	31.44M	31.53M	31.64M	31.84M	32.11M	32.02M	32.12M
Cash Dividends to Common per Share	$0.48	$0.52	$0.62	$0.72	$0.91	$1.16	$0.33	$1.00	$2.00	$2.50	$3.00

This table shows Interparfums' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026	9/30/2026
Net Income / (Loss) Attributable to Common Shareholders	10	41	37	62	24	42	32	66	43	30	68
Consolidated Net Income / (Loss)	8.23	53	47	77	27	55	41	83	57	37	88
Net Income / (Loss) Continuing Operations	8.23	53	47	77	27	55	41	83	57	37	88
Total Pre-Tax Income	15	70	61	100	37	73	54	108	75	48	117
Total Operating Income	19	68	65	106	36	75	59	109	74	49	118
Total Gross Profit	213	202	221	271	233	216	221	273	225	224	288
Total Revenue	329	324	342	425	362	339	334	430	345	341	430
Operating Revenue	329	324	342	425	362	339	334	430	345	341	430
Total Cost of Revenue	116	122	121	153	128	123	113	157	120	118	141
Operating Cost of Revenue	116	122	121	153	128	123	113	157	120	118	141
Total Operating Expenses	194	134	156	165	197	141	162	164	151	175	170
Selling, General & Admin Expense	194	134	156	165	193	141	162	164	151	175	170
Total Other Income / (Expense), net	-3.96	2.08	-3.58	-5.59	0.68	-1.67	-5.05	-1.00	1.07	-0.70	-0.42
Interest Expense	4.22	1.81	1.94	1.98	2.10	1.55	1.79	2.31	1.43	1.46	1.55
Interest & Investment Income	2.31	3.02	-1.08	-0.25	0.53	0.58	-1.93	2.55	2.32	0.69	1.31
Other Income / (Expense), net	-2.05	0.87	-0.56	-3.36	2.25	-0.70	-1.34	-1.24	0.19	0.07	-0.18
Income Tax Expense	6.69	17	15	24	9.98	18	13	24	19	11	29
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.19	12	9.78	15	2.47	13	9.21	17	13	6.40	20
Basic Earnings per Share	$0.33	$1.28	$1.15	$1.94	$0.76	$1.32	$1.00	$2.05	$1.35	$0.95	$2.13
Weighted Average Basic Shares Outstanding	31.99M	32.04M	32.02M	32.03M	32.04M	32.12M	32.11M	32.11M	32.03M	32.03M	32.03M
Diluted Earnings per Share	$0.32	$1.27	$1.14	$1.93	$0.78	$1.32	$0.99	$2.05	$1.35	$0.95	$2.13
Weighted Average Diluted Shares Outstanding	32.14M	32.27M	32.27M	32.27M	32.12M	32.17M	32.15M	32.15M	32.03M	32.03M	32.04M
Weighted Average Basic & Diluted Shares Outstanding	32.02M	32.02M	32.02M	32.03M	32.12M	32.12M	32.12M	32.06M	32.03M	32.03M	32.03M
Cash Dividends to Common per Share	$0.63	$0.75	$0.75	$0.75	$0.75	$0.80	$0.80	$0.80	$0.80	$0.80	$0.80

This table details how cash moves in and out of Interparfums' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-36	87	-15	47	-15	-60	36	-1.29	-64	-16	37
Net Cash From Operating Activities	37	50	55	36	63	76	65	120	73	106	188
Net Cash From Continuing Operating Activities	37	50	55	106	63	76	65	120	73	106	188
Net Income / (Loss) Continuing Operations	37	39	43	55	70	76	50	110	151	188	203
Consolidated Net Income / (Loss)	37	39	43	55	70	76	50	110	151	188	203
Depreciation Expense	10	9.08	15	12	11	8.73	9.07	13	23	17	28
Amortization Expense	-	-	-	-	-	-	-	-	4.98	5.45	6.27
Non-Cash Adjustments To Reconcile Net Income	0.60	0.97	-3.11	3.03	3.65	11	13	11	2.17	0.47	2.54
Changes in Operating Assets and Liabilities, net	-11	1.07	-0.92	-34	-21	-19	-6.69	-14	-108	-105	-53
Net Cash From Investing Activities	-37	-35	-20	37	-14	-65	-22	-188	-91	7.26	-45
Net Cash From Continuing Investing Activities	-37	-35	-20	37	-14	-65	-22	-188	-91	7.26	-45
Purchase of Property, Plant & Equipment	-3.30	-4.16	-4.78	-3.02	-3.96	-5.43	-11	-141	-34	-6.47	-4.74
Acquisitions	-0.92	-120	-0.97	-1.05	-8.51	-6.07	-15	-1.55	-57	-47	-18
Purchase of Investments	-246	-62	-57	-32	-10	-98	-7.58	-56	-1.04	-221	-206
Sale and/or Maturity of Investments	213	152	43	67	8.86	45	12	11	0.90	282	184
Net Cash From Financing Activities	-23	82	-45	-48	-56	-68	-19	78	-46	-133	-101
Net Cash From Continuing Financing Activities	-23	82	-45	-48	-56	-68	-19	78	-46	-133	-101
Repayment of Debt	-5.77	-12	-22	-22	-23	-22	-14	-43	-20	-29	-35
Repurchase of Common Equity	-0.09	-0.03	-0.08	-	-	-	-	0.00	0.00	-15	0.00
Payment of Dividends	-20	-20	-23	-27	-36	-50	-21	-42	-84	-101	-121
Issuance of Debt	0.00	111	-	-	0.00	0.00	13	157	52	4.33	48
Other Financing Activities, net	2.65	2.24	0.20	1.96	3.41	4.46	2.77	5.39	6.00	8.03	7.05
Effect of Exchange Rate Changes	-12	-10	-4.64	21	-8.73	-3.35	12	-11	-0.49	3.93	-5.07
Cash Interest Paid	1.51	2.40	2.24	1.81	1.75	1.76	1.11	2.47	2.99	5.82	7.50
Cash Income Taxes Paid	104	20	28	24	25	26	22	40	38	61	63

This table details how cash moves in and out of Interparfums' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026	9/30/2026
Net Change in Cash & Equivalents	8.70	-67	18	39	47	-29	55	-41	-78	90	-38
Net Cash From Operating Activities	81	-52	26	76	138	-7.36	12	64	0.09	46	57
Net Cash From Continuing Operating Activities	81	-52	26	76	138	-7.36	12	64	0.09	46	57
Net Income / (Loss) Continuing Operations	8.23	53	47	77	27	55	41	83	57	37	88
Consolidated Net Income / (Loss)	8.23	53	47	77	27	55	41	83	57	37	88
Depreciation Expense	4.55	6.02	6.00	6.18	10	5.93	6.36	6.55	5.80	5.83	-2.54
Amortization Expense	-	1.49	-	-	-	1.75	2.22	0.84	1.61	1.44	10
Non-Cash Adjustments To Reconcile Net Income	-4.89	-1.02	2.87	-3.08	0.79	0.44	0.20	1.71	0.97	-0.02	1.32
Changes in Operating Assets and Liabilities, net	68	-112	-30	-3.80	94	-71	-38	-29	-65	1.45	-40
Net Cash From Investing Activities	-33	14	37	-39	-56	14	11	-26	-27	115	-70
Net Cash From Continuing Investing Activities	-33	14	37	-39	-56	14	11	-26	-27	115	-70
Purchase of Property, Plant & Equipment	-1.89	-1.06	-1.06	-0.77	-1.85	-1.44	-15	-6.24	-1.36	-1.03	-1.52
Acquisitions	-45	-0.31	-0.27	-0.28	-17	-22	-1.36	0.97	-1.78	-0.96	-0.16
Purchase of Investments	-76	-60	-21	-66	-59	-32	-16	-46	-105	-11	-103
Sale and/or Maturity of Investments	89	75	59	28	22	69	43	25	82	128	34
Net Cash From Financing Activities	-43	-28	-44	0.08	-29	-38	26	-78	-50	-70	-26
Net Cash From Continuing Financing Activities	-43	-28	-44	0.08	-29	-38	26	-78	-50	-70	-26
Repayment of Debt	-6.27	-9.43	-6.53	-8.83	-9.91	-12	-11	-13	-15	-20	-13
Payment of Dividends	-21	-24	-48	-25	-24	-26	-53	-26	-27	-54	-75
Issuance of Debt	-14	4.00	10	34	-0.21	-1.05	91	-34	-4.68	4.68	62
Other Financing Activities, net	2.50	1.33	0.04	0.36	5.32	1.08	1.04	-	0.28	-	0.12
Effect of Exchange Rate Changes	3.19	-1.32	-0.21	2.16	-5.71	3.47	6.42	-0.60	-1.32	-0.92	1.90
Cash Interest Paid	1.16	1.13	3.14	2.31	0.92	1.40	1.63	1.96	1.35	1.20	1.36
Cash Income Taxes Paid	16	10	22	16	15	9.48	28	19	12	13	19

This table presents Interparfums' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	688	682	778	798	829	890	1,145	1,309	1,369	1,411	1,585
Total Current Assets	469	472	549	572	573	601	710	788	839	915	1,027
Cash & Equivalents	177	162	208	193	133	170	160	105	88	125	158
Short-Term Investments	83	94	70	68	120	127	160	151	94	109	137
Accounts Receivable	98	112	123	135	135	126	170	226	254	281	330
Inventories, net	98	97	137	162	168	159	199	290	372	372	351
Current Deferred & Refundable Income Taxes	7.28	0.63	3.47	0.81	0.17	2.81	0.21	0.16	0.69	0.31	11
Other Current Assets	5.81	6.24	7.36	13	17	17	21	16	29	27	40
Plant, Property, & Equipment, net	9.33	10	10	9.84	11	20	149	167	169	154	185
Total Noncurrent Assets	210	200	218	216	244	270	286	354	361	343	373
Intangible Assets	201	184	200	204	202	214	214	291	296	282	325
Noncurrent Deferred & Refundable Income Taxes	-	8.09	9.66	5.76	8.00	8.04	7.94	11	15	17	4.23
Other Noncurrent Operating Assets	8.23	8.25	8.01	6.30	34	48	64	52	50	43	44
Total Liabilities & Shareholders' Equity	688	682	778	798	829	890	1,145	1,309	1,369	1,411	1,585
Total Liabilities	211	199	207	212	220	188	407	520	477	469	481
Total Current Liabilities	131	142	167	189	184	156	245	345	325	332	344
Short-Term Debt	22	21	24	23	12	15	16	29	34	50	64
Accounts Payable	51	50	53	58	54	36	82	88	97	91	77
Accrued Expenses	47	63	82	95	96	96	137	214	179	173	190
Current Deferred & Payable Income Tax Liabilities	7.36	3.33	1.72	4.40	5.87	5.30	4.33	8.72	8.50	13	6.67
Other Current Liabilities	-	-	-	0.00	5.36	5.13	6.01	5.30	5.95	6.09	6.33
Total Noncurrent Liabilities	80	57	40	23	35	31	162	176	152	136	137
Long-Term Debt	76	53	36	23	11	10	133	151	128	116	121
Noncurrent Deferred & Payable Income Tax Liabilities	3.75	3.45	3.82	-	-	-	-	-	-	-	0.00
Other Noncurrent Operating Liabilities	-	-	-	-	25	-	29	-	25	-	16
Total Equity & Noncontrolling Interests	476	484	571	586	609	702	738	788	892	943	1,104
Total Preferred & Common Equity	366	370	433	448	468	536	572	617	699	745	881
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	366	370	433	448	468	536	572	617	699	745	881
Common Stock	62	63	66	70	71	76	87	90	99	107	128
Retained Earnings	388	403	423	449	475	504	561	620	694	763	829
Treasury Stock	-37	-37	-37	-37	-37	-37	-37	-37	-53	-53	-67
Accumulated Other Comprehensive Income / (Loss)	-48	-58	-18	-34	-40	-6.00	-38	-56	-40	-72	-9.03
Noncontrolling Interest	111	113	137	138	141	167	166	171	193	198	223

This table presents Interparfums' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026	9/30/2026
Total Assets	1,352	1,394	1,349	1,364	1,481	1,441	1,562	1,565	1,543	1,490	1,576
Total Current Assets	823	877	833	857	956	911	987	991	998	951	1,044
Cash & Equivalents	74	80	21	39	78	97	151	110	80	170	132
Short-Term Investments	112	104	76	38	79	75	54	77	157	42	108
Accounts Receivable	251	302	299	304	359	309	304	374	339	311	383
Inventories, net	360	364	400	434	413	396	425	388	370	376	376
Current Deferred & Refundable Income Taxes	0.39	0.50	2.49	19	0.53	0.06	2.02	0.00	7.81	3.76	0.12
Other Current Assets	25	27	34	24	27	35	50	41	45	49	45
Plant, Property, & Equipment, net	168	163	164	161	166	159	185	186	179	176	174
Total Noncurrent Assets	360	355	352	346	358	371	389	388	366	363	358
Intangible Assets	292	287	288	282	291	312	333	328	317	312	308
Noncurrent Deferred & Refundable Income Taxes	14	16	16	17	20	16	13	15	5.31	9.85	9.04
Other Noncurrent Operating Assets	53	52	49	46	47	42	43	44	43	41	40
Total Liabilities & Shareholders' Equity	1,352	1,394	1,349	1,364	1,481	1,441	1,562	1,565	1,543	1,490	1,576
Total Liabilities	505	518	441	463	495	433	505	460	430	399	474
Total Current Liabilities	342	363	302	332	340	306	333	303	306	287	313
Short-Term Debt	34	46	37	47	53	51	101	66	55	49	47
Accounts Payable	91	87	106	109	97	99	93	67	85	83	81
Accrued Expenses	194	200	136	145	166	129	127	153	151	146	168
Current Deferred & Payable Income Tax Liabilities	17	24	17	26	17	22	5.57	11	8.78	2.99	11
Other Current Liabilities	5.24	5.69	5.93	5.95	6.19	6.15	6.25	6.19	6.21	6.15	6.14
Total Noncurrent Liabilities	163	154	139	130	156	127	172	157	124	112	161
Long-Term Debt	139	129	116	108	135	107	153	140	107	97	147
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	-	2.50	2.48	1.61
Other Noncurrent Operating Liabilities	24	25	-	-	-	-	-	17	-	13	12
Total Equity & Noncontrolling Interests	847	877	908	901	985	1,008	1,057	1,104	1,113	1,091	1,103
Total Preferred & Common Equity	668	690	708	717	778	789	839	871	882	870	878
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	668	690	708	717	778	789	839	871	882	870	878
Common Stock	96	96	100	101	101	108	109	109	128	128	95
Retained Earnings	670	703	711	724	763	780	787	827	847	839	881
Treasury Stock	-49	-49	-53	-53	-53	-53	-55	-60	-71	-71	-71
Accumulated Other Comprehensive Income / (Loss)	-49	-60	-50	-55	-33	-47	-1.60	-4.78	-22	-25	-27
Noncontrolling Interest	179	187	200	184	207	219	217	234	231	220	224

This table displays calculated financial ratios and metrics derived from Interparfums' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
DEI Shares Outstanding	-	-	-	-	-	-	-	-	31,875,625.00	63,961,610.00	32,030,280.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	31,875,625.00	63,961,610.00	32,030,280.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	3.79	2.39	5.13
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-11.41%	-6.15%	11.21%	13.47%	14.26%	5.62%	-24.46%	63.17%	23.55%	21.26%	10.22%
EBITDA Growth	-27.31%	7.65%	17.32%	9.29%	18.57%	6.46%	-30.99%	110.44%	34.81%	24.13%	13.09%
EBIT Growth	-30.01%	11.09%	9.54%	16.63%	22.58%	9.65%	-33.92%	119.77%	27.89%	30.04%	9.55%
NOPAT Growth	-29.35%	12.12%	9.05%	29.44%	23.80%	9.98%	-33.35%	113.61%	40.09%	25.16%	10.13%
Net Income Growth	-26.73%	4.35%	10.98%	27.76%	26.17%	9.12%	-34.31%	120.19%	37.27%	24.32%	8.34%
EPS Growth	-25.20%	3.16%	9.18%	24.30%	28.57%	11.11%	-36.32%	127.27%	37.45%	25.66%	7.79%
Operating Cash Flow Growth	-25.57%	36.79%	8.95%	-34.22%	75.65%	21.27%	-14.99%	84.00%	-38.93%	44.83%	77.40%
Free Cash Flow Firm Growth	45.23%	-213.43%	195.44%	-93.43%	1,262.61%	34.44%	-118.79%	-196.24%	-146.32%	398.49%	238.73%
Invested Capital Growth	-6.47%	43.50%	-3.68%	16.93%	5.53%	2.61%	16.15%	31.96%	29.86%	18.23%	2.61%
Revenue Q/Q Growth	4.09%	-1.43%	3.26%	2.56%	4.28%	0.08%	1.17%	3.13%	10.14%	1.38%	2.31%
EBITDA Q/Q Growth	29.94%	1.10%	7.83%	-4.60%	18.68%	1.37%	19.51%	-17.15%	23.77%	-1.33%	12.09%
EBIT Q/Q Growth	38.42%	1.41%	0.07%	-0.78%	6.27%	1.84%	22.87%	-19.69%	19.27%	-0.82%	8.48%
NOPAT Q/Q Growth	41.01%	-4.44%	7.33%	3.21%	5.53%	-0.80%	23.78%	-19.55%	20.94%	-3.75%	7.78%
Net Income Q/Q Growth	37.39%	-5.47%	7.67%	2.18%	5.12%	-0.44%	21.87%	-17.45%	17.41%	-4.43%	9.98%
EPS Q/Q Growth	31.94%	-3.92%	5.94%	0.76%	7.55%	0.00%	22.22%	0.00%	17.03%	-4.04%	9.87%
Operating Cash Flow Q/Q Growth	153.15%	34.22%	9.11%	-29.64%	30.61%	4.02%	31.05%	-35.85%	619.52%	0.27%	43.04%
Free Cash Flow Firm Q/Q Growth	145.14%	21.87%	30.98%	-89.53%	55.97%	33.79%	-144.09%	-211.02%	-583.06%	107.35%	655.98%
Invested Capital Q/Q Growth	-17.65%	-17.04%	-19.73%	-10.70%	-13.07%	-16.03%	-5.07%	3.35%	5.50%	0.31%	-13.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	57.49%	61.78%	62.65%	63.64%	63.29%	62.50%	61.36%	63.32%	63.90%	63.68%	63.85%
EBITDA Margin	12.91%	14.81%	15.63%	15.05%	15.62%	15.74%	14.38%	18.55%	20.23%	20.71%	21.25%
Operating Margin	10.70%	13.06%	12.80%	13.30%	14.02%	14.68%	13.00%	16.83%	17.88%	19.08%	18.92%
EBIT Margin	10.88%	12.88%	12.68%	13.04%	13.99%	14.52%	12.70%	17.11%	17.70%	18.98%	18.87%
Profit (Net Income) Margin	7.48%	8.32%	8.30%	9.35%	10.32%	10.66%	9.27%	12.51%	13.90%	14.25%	14.01%
Tax Burden Percent	65.85%	64.42%	64.48%	70.78%	72.73%	72.35%	72.05%	72.86%	77.77%	75.23%	75.80%
Interest Burden Percent	104.44%	100.28%	101.50%	101.29%	101.46%	101.49%	101.31%	100.38%	100.98%	99.79%	97.95%
Effective Tax Rate	34.15%	35.58%	35.52%	29.22%	27.27%	27.65%	27.95%	27.14%	22.23%	24.77%	24.20%
Return on Invested Capital (ROIC)	15.28%	14.56%	13.72%	16.69%	18.65%	19.71%	12.00%	20.57%	23.17%	23.52%	23.60%
ROIC Less NNEP Spread (ROIC-NNEP)	14.52%	14.77%	13.57%	16.89%	18.25%	19.57%	12.23%	19.46%	23.23%	27.26%	37.57%
Return on Net Nonoperating Assets (RNNOA)	-8.06%	-6.56%	-4.71%	-6.20%	-6.59%	-6.98%	-4.38%	-5.29%	-3.38%	-1.17%	-1.42%
Return on Equity (ROE)	7.22%	7.99%	9.01%	10.48%	12.06%	12.73%	7.62%	15.27%	19.79%	22.35%	22.17%
Cash Return on Invested Capital (CROIC)	21.97%	-21.17%	17.46%	1.08%	13.26%	17.14%	-2.94%	-6.99%	-2.81%	6.81%	21.03%
Operating Return on Assets (OROA)	8.56%	9.34%	9.65%	10.56%	11.99%	12.74%	7.96%	14.78%	15.68%	18.68%	19.71%
Return on Assets (ROA)	5.89%	6.03%	6.31%	7.57%	8.85%	9.35%	5.81%	10.81%	12.31%	14.02%	14.63%
Return on Common Equity (ROCE)	5.51%	6.13%	6.91%	7.99%	9.19%	9.76%	5.83%	11.74%	15.41%	17.51%	17.45%
Return on Equity Simple (ROE_SIMPLE)	9.77%	10.66%	11.68%	12.75%	15.58%	16.25%	9.33%	19.24%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	35	39	43	56	69	76	50	108	151	189	208
NOPAT Margin	7.04%	8.41%	8.25%	9.41%	10.20%	10.62%	9.37%	12.26%	13.91%	14.35%	14.34%
Net Nonoperating Expense Percent (NNEP)	0.76%	-0.21%	0.15%	-0.20%	0.39%	0.14%	-0.23%	1.10%	-0.06%	-3.74%	-13.97%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	15.22%	17.94%	18.45%
Cost of Revenue to Revenue	42.51%	38.22%	37.35%	36.36%	36.71%	37.50%	38.64%	36.68%	36.10%	36.32%	36.15%
SG&A Expenses to Revenue	46.80%	48.72%	49.66%	49.99%	49.27%	47.82%	48.36%	46.21%	45.31%	44.60%	44.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	46.80%	48.72%	49.86%	50.34%	49.27%	47.82%	48.36%	46.49%	46.02%	44.60%	44.93%
Earnings before Interest and Taxes (EBIT)	54	60	66	77	94	104	68	150	192	250	274
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	64	69	81	89	106	112	78	163	220	273	309
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.00	1.85	2.57	2.98	4.45	4.83	3.53	5.95	4.60	6.19	5.44
Price to Tangible Book Value (P/TBV)	2.70	4.12	5.10	5.55	8.19	8.49	5.88	9.51	8.71	10.74	8.77
Price to Revenue (P/Rev)	1.53	1.44	1.83	2.18	2.95	3.17	3.51	3.87	2.61	3.28	2.79
Price to Earnings (P/E)	25.97	22.23	28.55	31.04	37.05	37.49	49.46	38.93	23.47	28.35	24.67
Dividend Yield	1.95%	2.39%	2.03%	1.75%	1.43%	1.62%	2.03%	0.94%	2.25%	1.85%	2.37%
Earnings Yield	3.85%	4.50%	3.50%	3.22%	2.70%	2.67%	2.02%	2.57%	4.26%	3.53%	4.05%
Enterprise Value to Invested Capital (EV/IC)	2.70	1.96	2.87	3.37	5.05	5.57	4.00	5.74	4.01	5.17	4.70
Enterprise Value to Revenue (EV/Rev)	1.20	1.34	1.70	2.05	2.84	3.04	3.35	3.90	2.72	3.42	2.90
Enterprise Value to EBITDA (EV/EBITDA)	9.32	9.02	10.85	13.61	18.16	19.32	23.31	21.01	13.46	16.49	13.62
Enterprise Value to EBIT (EV/EBIT)	11.07	10.38	13.37	15.71	20.28	20.95	26.39	22.79	15.38	17.99	15.35
Enterprise Value to NOPAT (EV/NOPAT)	17.10	15.88	20.55	21.76	27.82	28.64	35.78	31.78	19.58	23.80	20.19
Enterprise Value to Operating Cash Flow (EV/OCF)	16.42	12.50	16.19	33.73	30.40	28.38	27.80	28.67	40.51	42.55	22.41
Enterprise Value to Free Cash Flow (EV/FCFF)	11.89	0.00	16.14	336.71	39.11	32.94	0.00	0.00	0.00	82.14	22.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.21	0.15	0.11	0.08	0.04	0.07	0.24	0.26	0.18	0.20
Long-Term Debt to Equity	0.00	0.16	0.11	0.06	0.04	0.02	0.04	0.22	0.22	0.14	0.14
Financial Leverage	-0.55	-0.44	-0.35	-0.37	-0.36	-0.36	-0.36	-0.27	-0.15	-0.04	-0.04
Leverage Ratio	1.23	1.33	1.43	1.39	1.36	1.36	1.31	1.41	1.61	1.59	1.52
Compound Leverage Factor	1.28	1.33	1.45	1.40	1.38	1.38	1.33	1.42	1.62	1.59	1.48
Debt to Total Capital	0.06%	17.15%	13.36%	9.60%	7.29%	3.65%	6.15%	19.43%	20.59%	15.36%	16.49%
Short-Term Debt to Total Capital	0.06%	3.85%	3.85%	3.86%	3.66%	1.95%	1.95%	1.74%	2.88%	3.23%	4.42%
Long-Term Debt to Total Capital	0.00%	13.29%	9.51%	5.74%	3.63%	1.70%	4.21%	17.69%	17.72%	12.13%	12.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	23.38%	19.27%	20.29%	21.76%	21.86%	22.31%	22.26%	18.16%	17.27%	18.29%	17.52%
Common Equity to Total Capital	76.56%	63.58%	66.35%	68.65%	70.85%	74.04%	71.59%	62.41%	62.14%	66.35%	65.99%
Debt to EBITDA	0.00	1.42	0.92	0.68	0.44	0.21	0.59	1.09	0.93	0.59	0.60
Net Debt to EBITDA	-4.34	-2.32	-2.23	-2.45	-2.04	-2.05	-3.23	-0.87	-0.23	-0.08	-0.16
Long-Term Debt to EBITDA	0.00	1.10	0.65	0.41	0.22	0.10	0.41	0.99	0.80	0.47	0.44
Debt to NOPAT	0.01	2.50	1.73	1.09	0.67	0.30	0.91	1.65	1.35	0.86	0.89
Net Debt to NOPAT	-7.96	-4.09	-4.22	-3.91	-3.12	-3.04	-4.96	-1.31	-0.34	-0.11	-0.23
Long-Term Debt to NOPAT	0.00	1.94	1.23	0.65	0.33	0.14	0.62	1.50	1.16	0.68	0.65
Altman Z-Score	7.09	4.27	5.36	6.18	8.24	8.80	8.29	7.39	5.66	8.17	8.11
Noncontrolling Interest Sharing Ratio	23.67%	23.33%	23.34%	23.77%	23.82%	23.36%	23.46%	23.11%	22.13%	21.67%	21.29%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.70	3.58	3.32	3.29	3.02	3.11	3.85	2.90	2.29	2.58	2.75
Quick Ratio	3.59	2.73	2.59	2.40	2.10	2.10	2.70	2.00	1.40	1.35	1.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	51	-57	55	3.60	49	66	-12	-37	-18	55	186
Operating Cash Flow to CapEx	1,108.81%	1,204.52%	1,142.22%	1,187.26%	1,593.55%	1,408.73%	590.26%	84.65%	216.35%	1,636.10%	3,958.69%
Free Cash Flow to Firm to Interest Expense	34.20	-20.29	23.39	1.81	19.01	30.70	-6.28	-12.98	-5.10	4.87	23.72
Operating Cash Flow to Interest Expense	24.77	17.72	23.32	18.02	24.45	35.63	32.99	42.33	20.29	9.40	23.98
Operating Cash Flow Less CapEx to Interest Expense	22.54	16.25	21.28	16.50	22.92	33.10	27.40	-7.68	10.91	8.83	23.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.79	0.73	0.76	0.81	0.86	0.88	0.63	0.86	0.89	0.98	1.04
Accounts Receivable Turnover	5.74	4.95	4.97	5.02	5.23	5.28	4.13	5.95	5.49	5.48	5.43
Inventory Turnover	1.93	1.78	1.99	1.84	1.66	1.62	1.28	1.80	1.60	1.45	1.41
Fixed Asset Turnover	50.86	50.60	53.69	57.95	66.99	68.13	35.13	10.41	6.88	7.84	8.99
Accounts Payable Turnover	4.11	3.68	3.89	4.21	4.47	4.76	4.65	5.49	4.60	5.15	5.57
Days Sales Outstanding (DSO)	63.61	73.68	73.46	72.66	69.85	69.19	88.35	61.31	66.50	66.57	67.24
Days Inventory Outstanding (DIO)	188.91	204.52	183.18	198.69	219.90	224.79	286.20	202.37	227.48	252.38	258.56
Days Payable Outstanding (DPO)	88.90	99.15	93.92	86.69	81.63	76.68	78.58	66.50	79.27	70.85	65.51
Cash Conversion Cycle (CCC)	163.61	179.05	162.73	184.66	208.12	217.30	295.98	197.18	214.71	248.10	260.28
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	222	319	307	360	379	389	452	597	737	871	894
Invested Capital Turnover	2.17	1.73	1.66	1.77	1.83	1.86	1.28	1.68	1.67	1.64	1.65
Increase / (Decrease) in Invested Capital	-15	97	-12	52	20	9.90	63	145	169	134	23
Enterprise Value (EV)	601	626	883	1,211	1,916	2,170	1,807	3,428	2,958	4,500	4,205
Market Capitalization	764	677	952	1,291	1,993	2,259	1,890	3,403	2,838	4,328	4,055
Book Value per Share	$12.35	$11.79	$11.91	$13.89	$14.29	$14.87	$16.99	$18.02	$19.35	$21.87	$23.26
Tangible Book Value per Share	$9.16	$5.30	$6.00	$7.46	$7.76	$8.45	$10.20	$11.28	$10.23	$12.60	$14.44
Total Capital	499	575	558	631	632	632	749	916	993	1,054	1,129
Total Debt	0.30	99	75	61	46	23	46	178	204	162	186
Total Long-Term Debt	0.00	76	53	36	23	11	31	162	176	128	136
Net Debt	-280	-161	-181	-218	-215	-230	-250	-142	-51	-21	-49
Capital Expenditures (CapEx)	3.30	4.16	4.78	3.02	3.96	5.43	11	141	34	6.47	4.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)	103	100	95	128	145	148	163	161	216	366	398
Debt-free Net Working Capital (DFNWC)	383	360	351	407	406	401	459	481	472	548	632
Net Working Capital (NWC)	383	338	330	382	382	389	445	465	443	514	582
Net Nonoperating Expense (NNE)	-2.18	0.46	-0.26	0.39	-0.82	-0.30	0.53	-2.16	0.07	1.35	4.85
Net Nonoperating Obligations (NNO)	-276	-157	-176	-211	-206	-220	-250	-142	-51	-21	-49
Total Depreciation and Amortization (D&A)	10	9.08	15	12	11	8.73	9.07	13	28	23	35
Debt-free, Cash-free Net Working Capital to Revenue	20.62%	21.35%	18.30%	21.70%	21.40%	20.75%	30.20%	18.32%	19.89%	27.74%	27.38%
Debt-free Net Working Capital to Revenue	76.76%	76.80%	67.44%	68.76%	60.03%	56.22%	85.17%	54.66%	43.41%	41.61%	43.54%
Net Working Capital to Revenue	76.70%	72.07%	63.31%	64.64%	56.61%	54.50%	82.47%	52.85%	40.78%	39.03%	40.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.95	$0.98	$1.07	$1.33	$1.72	$1.92	$1.21	$2.76	$3.80	$4.77	$5.13
Adjusted Weighted Average Basic Shares Outstanding	30.93M	31.00M	31.07M	31.17M	31.31M	31.45M	31.54M	31.68M	31.86M	31.99M	32.04M
Adjusted Diluted Earnings per Share	$0.95	$0.98	$1.07	$1.33	$1.71	$1.90	$1.21	$2.75	$3.78	$4.75	$5.12
Adjusted Weighted Average Diluted Shares Outstanding	31.06M	31.10M	31.18M	31.31M	31.52M	31.69M	31.65M	31.84M	31.99M	32.14M	32.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31M	31.10M	31.20M	31.30M	31.30M	0.00	31.64M	31.84M	32.11M	32.02M	32.12M
Normalized Net Operating Profit after Tax (NOPAT)	35	39	47	57	69	76	50	110	157	189	211
Normalized NOPAT Margin	7.04%	8.41%	8.95%	9.67%	10.20%	10.62%	9.37%	12.46%	14.46%	14.35%	14.55%
Pre Tax Income Margin	11.36%	12.91%	12.87%	13.20%	14.19%	14.74%	12.87%	17.17%	17.87%	18.94%	18.48%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	36.74	21.35	28.24	38.69	36.65	48.28	34.75	53.25	53.44	22.23	35.02
NOPAT to Interest Expense	23.79	13.95	18.37	27.94	26.72	35.31	25.63	38.18	41.98	16.81	26.62
EBIT Less CapEx to Interest Expense	34.51	19.88	26.20	37.17	35.11	45.75	29.16	3.25	44.06	21.65	34.41
NOPAT Less CapEx to Interest Expense	21.56	12.48	16.33	26.42	25.19	32.78	20.04	-11.83	32.61	16.23	26.01
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	52.24%	50.40%	52.90%	49.28%	51.35%	66.15%	42.29%	37.74%	55.75%	53.99%	59.36%
Augmented Payout Ratio	52.48%	50.49%	53.08%	49.28%	51.35%	66.15%	42.29%	37.74%	55.75%	62.18%	59.36%

This table displays calculated financial ratios and metrics derived from Interparfums' official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026	9/30/2026
DEI Shares Outstanding	63,961,610.00	63,961,610.00	32,023,640.00	32,024,280.00	32,030,280.00	32,123,940.00	32,124,000.00	32,117,600.00	32,064,728.00	32,025,781.00	32,025,781.00
DEI Adjusted Shares Outstanding	63,961,610.00	63,961,610.00	32,023,640.00	32,024,280.00	32,030,280.00	32,123,940.00	32,124,000.00	32,117,600.00	32,064,728.00	32,025,781.00	32,025,781.00
DEI Earnings Per Adjusted Shares Outstanding	0.16	0.64	1.15	1.94	0.76	1.32	1.00	2.05	1.35	0.95	2.13
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.78%	3.93%	10.67%	15.40%	9.97%	4.59%	-2.42%	1.17%	1.79%	2.13%	-0.02%
EBITDA Growth	-29.89%	-18.50%	19.60%	19.47%	126.38%	7.47%	-7.47%	3.95%	-0.39%	-15.28%	13.96%
EBIT Growth	-10.93%	-23.14%	15.23%	16.70%	127.23%	8.04%	-10.00%	4.56%	-0.07%	-15.26%	9.66%
NOPAT Growth	-44.26%	-25.20%	16.95%	21.84%	151.58%	9.55%	-8.67%	3.62%	-1.35%	-16.94%	5.29%
Net Income Growth	-51.39%	-24.83%	9.60%	16.21%	224.39%	3.94%	-11.59%	8.39%	2.35%	-10.47%	5.88%
EPS Growth	-38.46%	-24.40%	4.59%	16.27%	143.75%	3.94%	-13.16%	6.22%	2.27%	-4.04%	3.90%
Operating Cash Flow Growth	0.36%	-606.17%	80.56%	334.76%	69.29%	85.84%	-53.46%	-16.12%	101.16%	284.07%	-11.26%
Free Cash Flow Firm Growth	17.81%	14.13%	-13.00%	15.36%	102.83%	128.29%	35.37%	98.23%	-44.32%	276.72%	10,083.43%
Invested Capital Growth	18.23%	19.30%	20.33%	19.42%	2.61%	2.65%	12.23%	8.25%	3.84%	-8.86%	-5.89%
Revenue Q/Q Growth	-10.66%	-1.45%	5.64%	24.08%	-14.87%	-6.28%	-1.44%	28.64%	0.00%	-1.12%	25.94%
EBITDA Q/Q Growth	-76.85%	257.01%	-5.96%	53.70%	-56.13%	69.49%	-19.04%	72.67%	0.00%	-31.14%	122.52%
EBIT Q/Q Growth	-80.86%	308.93%	-6.64%	59.70%	-62.73%	94.43%	-22.23%	85.54%	0.00%	-34.05%	140.12%
NOPAT Q/Q Growth	-84.35%	396.59%	-4.64%	64.46%	-67.70%	116.24%	-20.51%	86.60%	0.00%	-33.06%	136.53%
Net Income Q/Q Growth	-87.55%	547.67%	-12.58%	64.89%	-65.25%	107.53%	-25.64%	102.15%	0.00%	-34.96%	139.08%
EPS Q/Q Growth	-80.72%	296.88%	-10.24%	69.30%	-59.59%	69.23%	-25.00%	107.07%	0.00%	-29.63%	124.21%
Operating Cash Flow Q/Q Growth	365.35%	-163.76%	149.08%	198.58%	81.19%	-105.33%	261.29%	438.11%	0.00%	53,525.88%	24.33%
Free Cash Flow Firm Q/Q Growth	-19.74%	12.91%	-11.18%	27.00%	104.00%	771.83%	-353.98%	98.00%	0.00%	706.14%	12.82%
Invested Capital Q/Q Growth	0.31%	13.28%	1.53%	3.52%	-13.81%	13.33%	11.01%	-0.16%	0.00%	-2.57%	3.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.70%	62.47%	64.51%	63.86%	64.46%	63.74%	66.21%	63.51%	65.13%	65.54%	67.10%
EBITDA Margin	6.50%	23.57%	20.98%	25.99%	13.39%	24.22%	19.89%	26.70%	23.70%	16.50%	29.16%
Operating Margin	5.74%	20.98%	18.94%	24.96%	9.96%	22.16%	17.72%	25.27%	21.50%	14.35%	27.44%
EBIT Margin	5.12%	21.25%	18.78%	24.17%	10.58%	21.95%	17.32%	24.98%	21.55%	14.37%	27.40%
Profit (Net Income) Margin	2.50%	16.45%	13.62%	18.09%	7.39%	16.35%	12.34%	19.39%	16.44%	10.81%	20.53%
Tax Burden Percent	55.16%	76.09%	76.08%	76.52%	72.78%	75.47%	76.11%	77.42%	75.40%	76.45%	75.07%
Interest Burden Percent	88.62%	101.76%	95.31%	97.83%	95.89%	98.70%	93.58%	100.23%	101.19%	98.44%	99.80%
Effective Tax Rate	44.84%	23.91%	23.92%	23.48%	27.22%	24.53%	23.89%	22.58%	24.60%	23.55%	24.93%
Return on Invested Capital (ROIC)	5.19%	23.40%	21.41%	28.45%	11.93%	24.53%	18.50%	26.52%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	11.26%	28.97%	15.13%	8.98%	10.50%	21.57%	13.95%	24.33%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-0.48%	0.94%	0.75%	0.21%	-0.40%	0.95%	1.20%	0.82%	0.00%	0.00%	0.00%
Return on Equity (ROE)	4.71%	24.34%	22.16%	28.67%	11.53%	25.49%	19.71%	27.34%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	6.81%	1.33%	1.03%	2.58%	21.03%	18.71%	8.12%	11.70%	-3.77%	9.27%	6.07%
Operating Return on Assets (OROA)	5.04%	20.71%	18.85%	23.87%	11.05%	23.09%	17.27%	24.02%	0.00%	0.00%	0.00%
Return on Assets (ROA)	2.46%	16.03%	13.67%	17.87%	7.71%	17.20%	12.30%	18.64%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	3.69%	18.93%	17.56%	22.61%	9.07%	19.92%	15.67%	21.58%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	10	52	49	81	26	57	45	84	56	37	88
NOPAT Margin	3.17%	15.96%	14.41%	19.10%	7.25%	16.72%	13.49%	19.57%	16.21%	10.97%	20.60%
Net Nonoperating Expense Percent (NNEP)	-6.07%	-5.56%	6.28%	19.47%	1.42%	2.97%	4.56%	2.18%	2.95%	46.85%	-2.32%
Return On Investment Capital (ROIC_SIMPLE)	0.99%	4.77%	4.57%	6.79%	2.32%	4.78%	3.39%	6.41%	4.34%	3.03%	6.82%
Cost of Revenue to Revenue	35.30%	37.53%	35.49%	36.14%	35.54%	36.26%	33.79%	36.49%	34.87%	34.46%	32.90%
SG&A Expenses to Revenue	58.96%	41.49%	45.56%	38.90%	53.40%	41.59%	48.49%	38.24%	43.64%	51.19%	39.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	58.96%	41.49%	45.56%	38.90%	54.51%	41.59%	48.49%	38.24%	43.64%	51.19%	39.66%
Earnings before Interest and Taxes (EBIT)	17	69	64	103	38	74	58	107	74	49	118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	76	72	110	48	82	66	115	82	56	125
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.19	6.00	4.93	5.10	5.44	4.49	4.90	3.56	3.30	4.12	4.05
Price to Tangible Book Value (P/TBV)	10.74	10.11	8.13	8.14	8.77	7.44	8.12	5.72	5.16	6.41	6.23
Price to Revenue (P/Rev)	3.28	3.19	2.59	2.80	2.79	2.42	2.82	2.12	0.00	0.00	0.00
Price to Earnings (P/E)	28.35	30.41	24.98	26.37	24.67	21.38	25.54	18.86	0.00	0.00	0.00
Dividend Yield	1.85%	1.98%	2.49%	2.32%	2.37%	2.76%	2.42%	3.26%	3.52%	2.86%	2.88%
Earnings Yield	3.53%	3.29%	4.00%	3.79%	4.05%	4.68%	3.92%	5.30%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.17	4.58	3.81	4.08	4.70	3.72	3.91	2.99	2.93	3.65	3.53
Enterprise Value to Revenue (EV/Rev)	3.42	3.40	2.80	2.98	2.90	2.57	3.01	2.29	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	16.49	18.20	14.75	15.36	13.62	11.99	14.23	10.71	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	17.99	19.73	16.06	16.74	15.35	13.48	16.10	12.08	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	23.80	26.36	21.37	21.88	20.19	17.68	21.04	15.83	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	42.55	73.98	52.65	32.24	22.41	16.23	20.11	16.26	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	82.14	375.89	403.41	172.27	22.66	20.15	50.92	26.55	0.00	37.51	56.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.19	0.20	0.21	0.20	0.18	0.26	0.19	0.16	0.13	0.18
Long-Term Debt to Equity	0.14	0.15	0.14	0.16	0.14	0.13	0.16	0.13	0.11	0.09	0.13
Financial Leverage	-0.04	0.03	0.05	0.02	-0.04	0.04	0.09	0.03	-0.03	0.00	-0.01
Leverage Ratio	1.59	1.55	1.55	1.54	1.52	1.46	1.49	1.46	1.41	1.42	1.42
Compound Leverage Factor	1.41	1.58	1.48	1.51	1.45	1.44	1.40	1.46	1.42	1.40	1.42
Debt to Total Capital	15.36%	16.25%	16.46%	17.53%	16.49%	14.98%	20.55%	15.74%	13.70%	11.78%	14.99%
Short-Term Debt to Total Capital	3.23%	3.45%	4.38%	4.48%	4.42%	4.30%	7.62%	5.06%	4.25%	3.98%	3.63%
Long-Term Debt to Total Capital	12.13%	12.81%	12.08%	13.05%	12.07%	10.68%	12.93%	10.68%	9.45%	7.81%	11.36%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	18.29%	18.43%	17.07%	17.30%	17.52%	18.47%	16.35%	17.82%	17.91%	17.81%	17.28%
Common Equity to Total Capital	66.35%	65.32%	66.47%	65.17%	65.99%	66.55%	63.11%	66.44%	68.39%	70.40%	67.73%
Debt to EBITDA	0.59	0.71	0.69	0.76	0.60	0.56	0.88	0.66	0.00	0.00	0.00
Net Debt to EBITDA	-0.08	0.32	0.39	0.19	-0.16	0.02	0.22	0.06	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.47	0.56	0.50	0.57	0.44	0.40	0.56	0.45	0.00	0.00	0.00
Debt to NOPAT	0.86	1.03	0.99	1.08	0.89	0.83	1.31	0.97	0.00	0.00	0.00
Net Debt to NOPAT	-0.11	0.46	0.56	0.27	-0.23	0.03	0.33	0.09	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.68	0.81	0.73	0.81	0.65	0.59	0.82	0.66	0.00	0.00	0.00
Altman Z-Score	7.61	8.14	6.94	7.22	7.56	7.36	7.15	6.47	5.53	6.81	6.09
Noncontrolling Interest Sharing Ratio	21.67%	22.25%	20.76%	21.12%	21.29%	21.86%	20.51%	21.07%	21.22%	20.38%	20.74%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	2.75	2.58	2.82	2.75	2.97	2.96	3.27	3.26	3.31	3.33
Quick Ratio	1.35	1.31	1.15	1.52	1.55	1.57	1.53	1.86	1.88	1.82	1.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-124	-108	-120	-88	3.50	31	-78	-1.55	17	137	155
Operating Cash Flow to CapEx	4,309.68%	-4,906.52%	2,398.97%	9,926.99%	7,453.32%	-510.97%	78.13%	1,024.27%	6.24%	4,442.69%	3,740.66%
Free Cash Flow to Firm to Interest Expense	-29.34	-59.72	-61.82	-44.28	1.67	19.76	-43.39	-0.67	11.85	94.06	99.49
Operating Cash Flow to Interest Expense	19.30	-28.75	13.14	38.49	65.73	-4.76	6.64	27.71	0.06	31.28	36.47
Operating Cash Flow Less CapEx to Interest Expense	18.85	-29.34	12.59	38.11	64.85	-5.69	-1.86	25.00	-0.89	30.58	35.49
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.98	0.97	1.00	0.99	1.04	1.05	1.00	0.96	0.00	0.00	0.00
Accounts Receivable Turnover	5.48	4.68	4.91	4.30	5.43	4.83	4.79	3.99	0.00	0.00	0.00
Inventory Turnover	1.45	1.36	1.24	1.32	1.41	1.32	1.21	1.30	0.00	0.00	0.00
Fixed Asset Turnover	7.84	7.98	8.28	8.62	8.99	9.08	8.42	8.30	0.00	0.00	0.00
Accounts Payable Turnover	5.15	4.93	4.93	5.58	5.57	5.13	5.13	6.37	0.00	0.00	0.00
Days Sales Outstanding (DSO)	66.57	78.00	74.41	84.96	67.24	75.55	76.13	91.40	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	252.38	268.85	294.40	276.67	258.56	276.08	302.88	280.65	0.00	0.00	0.00
Days Payable Outstanding (DPO)	70.85	74.01	74.01	65.42	65.51	71.13	71.10	57.30	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	248.10	272.84	294.80	296.21	260.28	280.50	307.92	314.75	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	871	987	1,002	1,037	894	1,013	1,125	1,123	1,052	1,025	1,057
Invested Capital Turnover	1.64	1.47	1.49	1.49	1.65	1.47	1.37	1.36	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	134	160	169	169	23	26	123	86	39	-100	-66
Enterprise Value (EV)	4,500	4,525	3,820	4,229	4,205	3,769	4,396	3,354	3,083	3,737	3,732
Market Capitalization	4,328	4,246	3,535	3,970	4,055	3,544	4,111	3,102	2,913	3,582	3,554
Book Value per Share	$21.87	$22.10	$22.39	$24.31	$23.26	$24.55	$26.13	$27.12	$27.53	$27.18	$27.43
Tangible Book Value per Share	$12.60	$13.11	$13.57	$15.23	$14.44	$14.83	$15.75	$16.90	$17.63	$17.44	$17.80
Total Capital	1,054	1,084	1,079	1,195	1,129	1,185	1,330	1,311	1,289	1,236	1,297
Total Debt	162	176	178	209	186	178	273	206	177	146	194
Total Long-Term Debt	128	139	130	156	136	127	172	140	122	97	147
Net Debt	-21	79	101	52	-49	5.62	68	18	-61	-66	-46
Capital Expenditures (CapEx)	1.89	1.06	1.06	0.77	1.85	1.44	15	6.24	1.36	1.03	1.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)	366	471	495	513	398	484	550	566	510	501	538
Debt-free Net Working Capital (DFNWC)	548	568	572	670	632	656	755	754	747	713	778
Net Working Capital (NWC)	514	530	525	617	582	605	654	688	692	664	731
Net Nonoperating Expense (NNE)	2.19	-1.58	2.72	4.28	-0.49	1.26	3.84	0.77	-0.81	0.53	0.32
Net Nonoperating Obligations (NNO)	-21	79	101	52	-49	5.62	68	18	-61	-66	-46
Total Depreciation and Amortization (D&A)	4.55	7.50	7.52	7.71	10	7.67	8.59	7.39	7.41	7.27	7.54
Debt-free, Cash-free Net Working Capital to Revenue	27.74%	35.38%	36.35%	36.15%	27.38%	32.97%	37.69%	38.69%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	41.61%	42.68%	41.98%	47.22%	43.54%	44.69%	51.77%	51.53%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	39.03%	39.87%	38.52%	43.45%	40.10%	41.21%	44.83%	47.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.33	$1.28	$1.15	$1.94	$0.76	$1.32	$1.00	$2.05	$1.35	$0.95	$2.13
Adjusted Weighted Average Basic Shares Outstanding	31.99M	32.04M	32.02M	32.03M	32.04M	32.12M	32.11M	32.11M	32.03M	32.03M	32.03M
Adjusted Diluted Earnings per Share	$0.32	$1.27	$1.14	$1.93	$0.78	$1.32	$0.99	$2.05	$1.35	$0.95	$2.13
Adjusted Weighted Average Diluted Shares Outstanding	32.14M	32.27M	32.27M	32.27M	32.12M	32.17M	32.15M	32.15M	32.03M	32.03M	32.04M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.02M	32.02M	32.02M	32.03M	32.12M	32.12M	32.12M	32.06M	32.03M	32.03M	32.03M
Normalized Net Operating Profit after Tax (NOPAT)	10	52	49	81	26	57	45	84	56	37	88
Normalized NOPAT Margin	3.17%	15.96%	14.41%	19.10%	7.25%	16.72%	13.49%	19.57%	16.21%	10.97%	20.60%
Pre Tax Income Margin	4.54%	21.62%	17.90%	23.65%	10.15%	21.67%	16.21%	25.04%	21.81%	14.15%	27.35%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.99	38.10	33.11	51.89	18.22	48.14	32.37	46.56	51.83	33.64	75.73
NOPAT to Interest Expense	2.47	28.62	25.41	41.01	12.48	36.67	25.21	36.46	38.98	25.68	56.95
EBIT Less CapEx to Interest Expense	3.54	37.51	32.56	51.50	17.34	47.21	23.87	43.85	50.88	32.94	74.76
NOPAT Less CapEx to Interest Expense	2.02	28.04	24.86	40.62	11.60	35.74	16.70	33.76	38.03	24.97	55.97
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	53.99%	61.65%	64.69%	63.65%	59.36%	59.71%	63.84%	62.17%	0.00%	0.00%	0.00%
Augmented Payout Ratio	62.18%	61.65%	67.04%	65.87%	59.36%	59.71%	64.86%	65.79%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Interparfums’ Q2 2026 results show strong cash generation and a healthier balance sheet, but profitability weakened compared with the prior year. Revenue was $341.0 million, up modestly from $333.9 million in Q2 2025 but down slightly from $344.9 million in Q1 2026. The company’s longer-term revenue trend remains favorable: quarterly revenue increased from $309.2 million in Q2 2023 to $341.0 million in Q2 2026.

Profitability was the main area of pressure. Gross profit rose to $223.5 million, but the gross margin slipped to approximately 65.5% from 66.2% a year earlier. Selling, general and administrative expenses increased 7.8% year over year, causing operating income to fall 17.3% to $48.9 million. Net income attributable to common shareholders declined 4.7% to $30.5 million, while diluted earnings per share fell to $0.95 from $0.99.

Cash flow improved substantially. Operating cash flow was $45.6 million in Q2 2026, compared with $11.9 million in Q2 2025 and only $85,000 in Q1 2026. The improvement was supported by changes in operating assets and liabilities, including lower inventory. However, the quarterly increase in cash was also heavily influenced by $128.1 million of investment sales and maturities, rather than solely by operating performance.

The balance sheet remains relatively strong. Cash and equivalents totaled $169.7 million, while short-term investments added $41.6 million. Total debt declined to approximately $145.7 million from $208.9 million a year earlier. Current assets were more than three times current liabilities, and inventory declined nearly 12% year over year. Interparfums also continued returning capital, paying $54.2 million in dividends during the quarter and reporting a dividend of $0.80 per share.

Operating cash flow rebounded sharply to $45.6 million in Q2 2026 from $11.9 million in Q2 2025 and $85,000 in Q1 2026.
Debt reduction strengthened the balance sheet. Total short- and long-term debt fell to approximately $145.7 million from $208.9 million year over year.
Liquidity remains ample. Cash and short-term investments totaled $212.3 million, and the current ratio was approximately 3.3.
Inventory management improved. Net inventory declined to $375.6 million from $425.3 million a year earlier, reducing working-capital needs.
Revenue remains well above historical levels. Q2 revenue increased from $309.2 million in 2023 to $341.0 million in 2026.
Shareholder returns remain a priority. The company paid $54.2 million in dividends during Q2 and maintained a $0.80 per-share dividend, above the $0.625 reported in 2023.
Cash increased by $89.8 million during Q2, but much of the investing inflow came from $128.1 million of investment sales and maturities, which may not be recurring.
Accounts receivable declined sequentially from $338.6 million in Q1 2026 to $310.8 million in Q2, although the year-over-year comparison still showed a modest increase.
Operating profitability deteriorated. Operating income fell 17.3% year over year to $48.9 million, and the operating margin declined to approximately 14.4% from 17.7%.
Higher operating expenses pressured earnings. SG&A increased to $174.6 million, up from $161.9 million a year earlier, while diluted EPS declined to $0.95 from $0.99.

11/11/26 04:08 PM ETAI Generated. May Contain Errors.

Interparfums Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Interparfums' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

Interparfums' net income appears to be on an upward trend, with a most recent value of $203.43 million in 2024, rising from $37.35 million in 2014. The previous period was $187.78 million in 2023. See Interparfums' forecast for analyst expectations on what's next for the company.

Interparfums' total operating income in 2024 was $274.80 million, based on the following breakdown:

Total Gross Profit: $927.34 million
Total Operating Expenses: $652.55 million

Over the last 10 years, Interparfums' total revenue changed from $499.26 million in 2014 to $1.45 billion in 2024, a change of 190.9%.

In the past 13 quarters, Interparfums' cash and equivalents has ranged from $20.98 million in Q1 2024 to $169.70 million in Q2 2026, and is currently $131.91 million as of their latest financial filing in Q3 2026.

Interparfums had total debt of $186.11 million at the end of 2024, a 14.9% increase from 2023, and a 62,352.0% increase since 2014.

Over the last 10 years, Interparfums' book value per share changed from 12.35 in 2014 to 23.26 in 2024, a change of 88.3%.

Related Companies

Financial statements for NASDAQ:IPAR last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Interparfums (IPAR) Financials

Financials Breakdown Chart

Key Financial Trends

Interparfums Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Interparfums (IPAR) Financials

Annual Income Statements for Interparfums

Quarterly Income Statements for Interparfums

Annual Cash Flow Statements for Interparfums

Quarterly Cash Flow Statements for Interparfums

Annual Balance Sheets for Interparfums

Quarterly Balance Sheets for Interparfums

Annual Metrics And Ratios for Interparfums

Quarterly Metrics And Ratios for Interparfums

Financials Breakdown Chart

Key Financial Trends

Interparfums Financials - Frequently Asked Questions

When does Interparfums' fiscal year end?

How has Interparfums' net income changed over the last 10 years?

What is Interparfums' operating income?

How has Interparfums' revenue changed over the last 10 years?

How much cash does Interparfums have?

How much debt does Interparfums have?

How has Interparfums' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools